News
FDA Gives Marketing Nod to Blood Test for Diagnosing Alzheimer Disease
The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the U.S. Food and Drug Administration. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is approved for the early detection of amyloid plaques associated with Alzheimer disease in patients aged 55 years and older who are showing signs of the disease.
Alzheimer’s disease is the most common form of dementia — accounting for 60 to 80% of cases in the US. As such, it is easy to ...
Dementia usually affects older people, so when it occurs in middle age, it can be hard to recognize. The most common form is frontotemporal dementia (FTD), which is often mistaken for depression, ...
According to the Alzheimer’s Association: “An estimated 7.2 million Americans age 65 and older are living with Alzheimer’s ...
3don MSN
The only actual available "test" for Alzheimer’s disease in younger people would be to check someone's APOE 4 levels, which ...
While many people know that issues with memory can be an early sign of dementia, fewer people understand that symptoms also ...
The ex-professional received his initial dementia diagnosis in January 2024 Windass has since been candid about his ...
John Ramsay experienced the devastating impact of young-onset dementia firsthand, witnessing his father, David, battle the disease for a decade. David's diagnosis came when John was just 12 ...
More than 60 million people are estimated to be living with dementia, resulting in over 1.5 million deaths a year and an ...
Every year in clinics across the country, thousands of people are asked to draw the face of a clock, repeat lists of words and complete seemingly simple tasks. Many leave with life-changing news: ...
WarwickshireWorld on MSN1d
Age UK calls for early dementia diagnosis during Dementia Action Week 2025May 2025, aims to raise awareness about dementia and the importance of early diagnosis. In Coventry and Warwickshire, ...
Older adults vaccinated against herpes zoster, or shingles, had a reduced risk of developing dementia, over a period of 7 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback